N/A (Busulfan)
Busulfan injection is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic…
Medication Brand Names Beginning with ‘N’
N/A (Atropine Injection, 2 Mg)
Atropine is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity as well as organophosphorus or carbamate insecticides…
NA (Duloxetine Delayed-release Capsules)
Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder [see Clinical Studies (14.1). ] Generalized Anxiety Disorder [see Clinical Studies (14.2)…
NA (Ticagrelor)
BRILINTA is indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction…
NABI-HB (HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN)
INDICATIONS AND USAGE Nabi-HB. Hepatitis B Immune Globulin (Human), is indicated for treatment of acute exposure to blood containing HBsAg, perinatal exposure of infants born to…